{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:44:53Z","timestamp":1767134693527,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd003149.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T00:00:00Z","timestamp":1459900800000}}],"reference-count":67,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003149.pub3","type":"journal-article","created":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T13:29:14Z","timestamp":1460122154000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Preoperative blood transfusions for sickle cell disease"],"prefix":"10.1002","author":[{"given":"Lise J","family":"Estcourt","sequence":"first","affiliation":[{"name":"NHS Blood and Transplant; Haematology\/Transfusion Medicine; Level 2, John Radcliffe Hospital Headington Oxford UK OX3 9BQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia M","family":"Fortin","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant; Systematic Review Initiative; John Radcliffe Hospital Oxford UK OX3 9BQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marialena","family":"Trivella","sequence":"additional","affiliation":[{"name":"University of Oxford; Centre for Statistics in Medicine; Botnar Research Centre Windmill Road Oxford UK OX3 7LD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Hopewell","sequence":"additional","affiliation":[{"name":"University of Oxford; Oxford Clinical Trials Research Unit; NDORMS Windmill Road Oxford Oxfordshire UK OX3 7LD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,4,6]]},"reference":[{"issue":"11 Pt 2 of 2","key":"10.1002\/14651858.CD003149.pub3-BIB0001|cit1","first-page":"21b","article-title":"The safety of avoiding transfusion preoperatively in patients with sickle cell hemoglobinopathies [abstract]","volume":"100","author":"Al-Jaouni","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD003149.pub3-BIB0002|cit2","first-page":"164","article-title":"Randomized clinical trial to evaluate the safety of avoiding pre-operative transfusion in sickle cell anemia","volume":"28","author":"Al-Jaouni","year":"2006","journal-title":"Bahrain Medical Bulletin"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(12)61726-7","article-title":"The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial","volume":"381","author":"Howard","year":"2013","journal-title":"Lancet"},{"issue":"21","key":"10.1002\/14651858.CD003149.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"Abstract no: 9","DOI":"10.1182\/blood.V118.21.9.9","article-title":"Pre-operative transfusion reduces serious adverse events in patients with sickle cell disease (SCD): Results from the transfusion alternatives preoperatively in sickle cell disease (TAPS) randomised controlled multicentre clinical trial [abstract]","volume":"118","author":"Howard","year":"2011","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0005|cit5","unstructured":"NCT00512577 Transfusion alternatives pre-operatively in sickle cell disease (TAPS) https:\/\/clinicaltrials.gov\/show\/NCT00512577"},{"issue":"3","key":"10.1002\/14651858.CD003149.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/ejh.12232","article-title":"Cost-effectiveness analysis of preoperative transfusion in patients with sickle cell disease using evidence from the TAPS trial","volume":"92","author":"Spackman","year":"2014","journal-title":"European Journal of Haematology"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD003149.pub3-BIB0007|cit7","first-page":"142a","article-title":"Cholecystectomy in sickle cell anemia (SCA) patients: report of 364 patients from the preoperative transfusion study [abstract]","volume":"86","author":"Haberkern","year":"1995","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0008|cit8","unstructured":"Haberkern CM Neumayr L Earles AN Robertson S Black D Orringer EP Cholecystectomy in sickle cell anemia patients: report of 364 patients from the Preoperative Transfusion Study [abstract] Proceedings of the 21st Annual Meeting of the National Sickle Cell Disease Program 1996 45"},{"issue":"5","key":"10.1002\/14651858.CD003149.pub3-BIB0009|cit9","first-page":"1533","article-title":"Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group","volume":"89","author":"Haberkern","year":"1997","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD003149.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/(SICI)1096-8652(199802)57:2<101::AID-AJH2>3.0.CO;2-#","article-title":"Surgery in patients with hemoglobin SC disease. Preoperative Transfusion in Sickle Cell Disease Study Group","volume":"57","author":"Neumayr","year":"1998","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0011|cit11","first-page":"300a","article-title":"Is preoperative transfusion always necessary in sickle cell anemia (SCA)? [abstract]","volume":"86 Suppl","author":"Orringer","year":"1995","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0012|cit12","unstructured":"Preoperative Transfusion Study Group Preliminary report on preoperative transfusion study in sickle cell disease [abstract] Proceedings of the 14th Annual Meeting of the National Sickle Cell Disease Program 1989 63"},{"issue":"4","key":"10.1002\/14651858.CD003149.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1056\/NEJM199507273330402","article-title":"A comparison of conservative and aggressive transfusion regimes in the perioperative management of sickle cell disease","volume":"333","author":"Vichinsky","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003149.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1096-8652(199911)62:3<129::AID-AJH1>3.0.CO;2-J","article-title":"The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the National Sickle Cell Surgery Study Group","volume":"62","author":"Vichinsky","year":"1999","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0015|cit15","unstructured":"Vichinsky EP The NPTSG High rates of complications in sickle cell anemia (SCA) patients undergoing orthopedic surgery [abstract] Proceedings of the 22nd Annual Meeting of the National Sickle Cell Disease Program 1997 182"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0016|cit16","unstructured":"Waldron P Pegelow C Neumayr L Haberkern C Earles A Wesman R ENT surgery in sickle cell disease: perioperative morbidity [abstract] Proceedings of the 22nd Annual Meeting of the National Sickle Cell Disease Program 1997 124"},{"issue":"2","key":"10.1002\/14651858.CD003149.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00043426-199903000-00009","article-title":"Tonsillectomy, adenoidectomy and myringotomy in sickle cell disease: perioperative morbidity","volume":"21","author":"Waldron","year":"1999","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0018|cit18","first-page":"463","article-title":"Preoperative transfusion in patients with sickle cell disease to prevent perioperative complications: a systematic review and meta-analysis","volume":"19","author":"Alotaibi","year":"2014","journal-title":"Hematology (Amsterdam, Netherlands)"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4293\/108680811X13176785203996","article-title":"Blood transfusion in patients with sickle cell disease requiring laparoscopic cholecystectomy","volume":"15","author":"Aziz","year":"2011","journal-title":"Journal of the Society of Laparoendoscopic Surgeons"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3109\/03630269.2013.828301","article-title":"Perinatal outcome in sickle cell anemia: a prospective study from India","volume":"37","author":"Daigavane","year":"2013","journal-title":"Hemoglobin"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1182\/asheducation-2007.1.482","article-title":"Limitations of clinical trials in sickle cell disease: a case study of the Multi-center Study of Hydroxyurea (MSH) trial and the Stroke Prevention (STOP) trial","volume":"2007","author":"Debaun","year":"2007","journal-title":"Hematology"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1479-828X.1995.tb02153.x","article-title":"Indications for blood transfusion in pregnancy with sickle cell disease","volume":"35","author":"El-Shafei","year":"1995","journal-title":"Australian & New Zealand Journal of Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijoa.2014.08.003","article-title":"Routine cell salvage during elective caesarean section: A pilot randomised trial","volume":"24","author":"Geoghegan","year":"2015","journal-title":"International Journal of Obstetric Anesthesia"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM198812013192204","article-title":"Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study","volume":"319","author":"Koshy","year":"1988","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0025|cit25","first-page":"300a","article-title":"Is preoperative transfusion always necessary in sickle cell anemia (SCA)? [abstract]","volume":"86","author":"Orringer","year":"1995","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2141.2006.06409.x","article-title":"Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2","volume":"136","author":"Styles","year":"2007","journal-title":"British Journal of Haematology"},{"issue":"1","key":"10.1002\/14651858.CD003149.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/0880010390158487","article-title":"A comparison of two transfusion regimens in the perioperative management of children with sickle cell disease undergoing adenotonsillectomy","volume":"20","author":"Wali","year":"2003","journal-title":"Pediatric Hematology and Oncology"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.amjmed.2008.04.040","article-title":"Surgical and obstetric outcomes in adults with sickle cell disease","volume":"121","author":"Adam","year":"2008","journal-title":"American Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003149.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood-2011-03-325258","article-title":"Fetal hemoglobin in sickle cell anemia","volume":"118","author":"Akinsheye","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD003149.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"e2013062","DOI":"10.4084\/mjhid.2013.062","article-title":"Sickle cell disease: management options and challenges in developing countries","volume":"5","author":"Ansong","year":"2013","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0609.2005.00412.x","article-title":"Preoperative transfusion in sickle cell disease: a survey of practice in England.[Erratum appears in Eur J Haematol. 2005 Sep;75(3):271]","volume":"75","author":"Buck","year":"2005","journal-title":"European Journal of Haematology"},{"issue":"1","key":"10.1002\/14651858.CD003149.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/archdischild-2013-303773","article-title":"Sickle cell disease: a neglected chronic disease of increasing global health importance","volume":"100","author":"Chakravorty","year":"2015","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1182\/asheducation-2013.1.439","article-title":"Transfusion therapy for sickle cell disease: a balancing act","volume":"2013","author":"Chou","year":"2013","journal-title":"Hematology"},{"issue":"6","key":"10.1002\/14651858.CD003149.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0035|cit35","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD003149.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1172\/JCI30920","article-title":"Sickle cell disease: old discoveries, new concepts, and future promise","volume":"117","author":"Frenette","year":"2007","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/515S1a","article-title":"Sickle-cell disease","volume":"515","author":"Gravitz","year":"2014","journal-title":"Nature"},{"issue":"6S4","key":"10.1002\/14651858.CD003149.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"S398","DOI":"10.1016\/j.amepre.2011.09.013","article-title":"Sickle cell disease in Africa. A neglected cause of early childhood mortality","volume":"41","author":"Grosse","year":"2011","journal-title":"American Journal of Preventive Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003149.pub3-BIB0039|cit39","first-page":"1533","article-title":"Cholecystectomy in sickle cell anaemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study","volume":"89","author":"Haberkern","year":"1997","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0040|cit40","unstructured":"Higgins JPT Deeks JJ (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0041|cit41","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0042|cit42","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1213\/ANE.0b013e3182a44d74","article-title":"Surgical procedures and outcomes among children with sickle cell disease","volume":"117","author":"Hyder","year":"2013","journal-title":"Anesthesia & Analgesia"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.blre.2013.09.001","article-title":"Management of sickle cell disease from childhood through adulthood","volume":"27","author":"Kanter","year":"2013","journal-title":"Blood Reviews"},{"issue":"6","key":"10.1002\/14651858.CD003149.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","article-title":"Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease","volume":"107","author":"Kato","year":"2006","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ajh.20642","article-title":"Cerebrovascular disease associated with sickle cell pulmonary hypertension","volume":"81","author":"Kato","year":"2006","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0047|cit47","unstructured":"NICE National Institute for Health and Care Excellence Sickle cell disease http:\/\/cks.nice.org.uk\/sickle-cell-disease#!backgroundsub:3"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tracli.2012.11.001","article-title":"Perioperative transfusion management in patients with sickle cell anaemia undergoing a total hip arthroplasty. Is there a role of red-cell exchange transfusion? A retrospective study in the CHU of Fort-de-France Martinique","volume":"20","author":"Ould Amar","year":"2013","journal-title":"Transfusion Clinique et Biologique"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/515S2a","article-title":"Epidemiology: a moving target","volume":"515","author":"Pleasants","year":"2014","journal-title":"Nature"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0051|cit51","first-page":"447","article-title":"Consequences and management of iron overload in sickle cell disease","volume":"1","author":"Porter","year":"2013","journal-title":"ASH Education Program Book"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0053|cit53","unstructured":"The Nordic Cochrane Centre Review Manager (RevMan) 2014"},{"issue":"6","key":"10.1002\/14651858.CD003149.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"e100516","DOI":"10.1371\/journal.pone.0100516","article-title":"The co-inheritance of alpha-thalassemia and sickle cell anemia Is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival","volume":"9","author":"Rumaney","year":"2014","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1002\/14651858.CD003149.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MAJ.0b013e3181c70e14","article-title":"Delayed hemolytic transfusion reaction in sickle cell disease","volume":"339","author":"Scheunemann","year":"2010","journal-title":"The American Journal of the Medical Sciences"},{"issue":"3","key":"10.1002\/14651858.CD003149.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1537-2995.1987.27387235626.x","article-title":"Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels. Implications for transfusion","volume":"27","author":"Schmalzer","year":"1987","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0057|cit57","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD003149.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjh.12336","article-title":"Interplay between coagulation and vascular inflammation in sickle cell disease","volume":"162","author":"Sparkenbaugh","year":"2013","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.joms.2012.12.004","article-title":"Sickle cell disease and perioperative considerations: review and retrospective report","volume":"71","author":"Stanley","year":"2013","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ajh.23232","article-title":"Genetic modifiers of sickle cell disease","volume":"87","author":"Steinberg","year":"2012","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0061|cit61","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD003149.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/2046-4053-3-54","article-title":"Study flow diagrams in Cochrane systematic review updates: an adapted PRISMA flow diagram","volume":"3","author":"Stovold","year":"2014","journal-title":"Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003149.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2141-9248.105655","article-title":"Prevalence of Human Immunodeficiency Virus Transmission among Transfused Children with Sickle Cell Anemia in Enugu Nigeria","volume":"2","author":"Ubesie","year":"2012","journal-title":"Annals of Medical and Health Sciences Research"},{"issue":"2","key":"10.1002\/14651858.CD003149.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00043426-199903000-00009","article-title":"Tonsillectomy, adenoidectomy and myringotomy in sickle cell disease: perioperative morbidity","volume":"21","author":"Waldron","year":"1999","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"issue":"10","key":"10.1002\/14651858.CD003149.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD003149.pub3-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003149","article-title":"Preoperative blood transfusions for sickle cell disease","author":"Hirst","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003149.pub3-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003149.pub2","article-title":"Preoperative blood transfusions for sickle cell disease","author":"Hirst","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003149.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003149.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:16:38Z","timestamp":1628529398000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003149.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,6]]},"references-count":67,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003149.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,6]]}}}